Researchers discussed Spark’s gene therapy and earlier-stage candidates.
Solutions under development include drugs and therapeutic contact lenses.
The company is positioning the glaucoma treatment as a superior type of prostaglandin analog.
CEO Brent Saunders said cost reductions will be implemented rapidly once planning is finished.
The country will allow the use of data from overseas multicenter clinical trials in marketing applications.
Officials plan to group lenses into four categories.
Texas-based Alcon saw growth in most market segments in Q3-2017.
One panel session looked at the recent trend of ophthalmologists joining companies as chief medical officers.
The explosive rise in costs for retinal care has pushed government officials to rethink reimbursement.
The segment is expected to grow at a rate of 5.2 percent from 2017 to 2022.
Five other ophthalmic companies raised financing in the past month, pushing the total raised during the time period to $220.6 million.
Defense attorneys built a portrait of their clients as simply friends, while prosecutors alleged that the defendants’ behavior amounted to bribery.
The company said lenses with an expiration of June 2020 or later are unaffected.
You are not currently logged in.
©2017 Market Scope
Lost your Password